INDP
Indaptus Therapeutics, Inc.
$3.27-0.16 (-4.66%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Indaptus Therapeutics, Inc. (INDP) is a publicly traded company with 7 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 2 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 19 transactions (past 365 days)
| 2026-02-27 | 2026-02-26 | Jabbour Jerome D | Director | Award | 25,000 | $0.00 | $0 |
| 2026-02-13 | 2026-02-11 | Meckler Jeffrey A | CEO | Award | 1,519 | $0.00 | $0 |
| 2026-02-13 | 2026-02-11 | Meckler Jeffrey A | CEO | Award | 3,033 | $0.00 | $0 |
| 2026-02-13 | 2026-02-11 | Meckler Jeffrey A | CEO | Award | 12,136 | $0.00 | $0 |
| 2026-02-13 | 2026-02-11 | Meckler Jeffrey A | CEO | Disposition | 12,136 | $0.00 | $0 |
| 2026-02-13 | 2026-02-11 | Meckler Jeffrey A | CEO | Disposition | 1,519 | $0.00 | $0 |
| 2026-02-13 | 2026-02-11 | Meckler Jeffrey A | CEO | Disposition | 3,033 | $0.00 | $0 |
| 2025-12-29 | 2025-12-22 | Newman Michael James | CSO | Award | 52,204 | $2.03 | $105,974 |
| 2025-12-29 | 2025-12-22 | Linscott Walt Addison | COO | Award | 54,421 | $2.03 | $110,475 |
| 2025-12-29 | 2025-12-22 | Meckler Jeffrey A | CEO | Award | 216,617 | $2.03 | $439,733 |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.